Literature DB >> 7513995

Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis.

Y Nunokawa1, N Ishida, S Tanaka.   

Abstract

We previously showed that interferon (IFN)-gamma inhibited the proliferation of rat vascular smooth muscle cells (VSMC) by generation of nitric oxide (NO) through the induction of an NO synthase (NOS) and cloned the rat inducible NOS cDNA in VSMC (VSM-NOS). To study the regulation of human inducible NOS (hiNOS) transcription in VSMC, we now cloned and sequenced a 2.9-kb fragment for the hiNOS gene containing a putative promoter, exon 1 and exon 2. The 5'-flanking region contains several consensus sequences for the binding of transcription factors involved in the inducibility of other genes by cytokines. These include IFN-gamma responsive element and NF-IL6 and NF-kappa B binding consensus sequences. Interestingly, hiNOS gene contains a shear-stress responsive element (GAGACC) which was also found to exist in human endothelial-type NOS but not in murine inducible NOS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513995     DOI: 10.1006/bbrc.1994.1522

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-kappa B.

Authors:  S V Spitsin; J L Farber; M Bertovich; G Moehren; H Koprowski; F H Michaels
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

Review 2.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter.

Authors:  S V Spitsin; H Koprowski; F H Michaels
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

4.  Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism.

Authors:  K T Akama; C Albanese; R G Pestell; L J Van Eldik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.

Authors:  A Weisz; L Cicatiello; H Esumi
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

6.  Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis.

Authors:  Jeffrey A Gold; Yoshihiko Hoshino; Satomi Hoshino; Marcus B Jones; Anna Nolan; Michael D Weiden
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 7.  The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells.

Authors:  D L Eizirik; M Flodström; A E Karlsen; N Welsh
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

8.  Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Authors:  Marc C Levesque; Maurine R Hobbs; Charles W O'Loughlin; Jennifer A Chancellor; Youwei Chen; Ariana N Tkachuk; Jennifer Booth; Kistie B Patch; Sallie Allgood; Ann R Pole; Carolyn A Fernandez; Esther D Mwaikambo; Theonest K Mutabingwa; Michal Fried; Bess Sorensen; Patrick E Duffy; Donald L Granger; Nicholas M Anstey; J Brice Weinberg
Journal:  Hum Genet       Date:  2009-10-27       Impact factor: 4.132

Review 9.  Nitric oxide synthase: expression and expressional control of the three isoforms.

Authors:  U Förstermann; H Kleinert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

10.  Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.

Authors:  C C Wu; J D Croxtall; M Perretti; C E Bryant; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.